ClinicalTrials.gov
ClinicalTrials.gov Menu

The Prevalence of Group B Streptococcus Positive Pregnant Patients in an Inner City Tertiary Care Center

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01251289
Recruitment Status : Completed
First Posted : December 1, 2010
Last Update Posted : June 11, 2012
Sponsor:
Information provided by (Responsible Party):
St. Michael's Hospital, Toronto

Brief Summary:
A retrospective review of the prevalence of Group B Streptococcus Positive Pregnant Patients in an Inner City Tertiary Care Center

Condition or disease
Group B Streptococcus

Detailed Description:
This is a retrospective chart review of the prevalence of Group B Streptococcus (GBS) positive patients

Study Type : Observational
Actual Enrollment : 628 participants
Observational Model: Cohort
Time Perspective: Retrospective
Official Title: The Prevalence of Group B Streptococcus Positive Pregnant Patients in an Inner City Tertiary Care Center
Study Start Date : December 2009
Actual Primary Completion Date : September 2010
Actual Study Completion Date : September 2010




Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   Child, Adult, Older Adult
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population
Group B streptococcus positive pregnant women
Criteria

Inclusion Criteria:

  • GBS positive pregnant women

Exclusion Criteria:


Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01251289


Sponsors and Collaborators
St. Michael's Hospital, Toronto
Investigators
Principal Investigator: Mark Yudin, MD St. Michael's Hospital, Toronto

Responsible Party: St. Michael's Hospital, Toronto
ClinicalTrials.gov Identifier: NCT01251289     History of Changes
Other Study ID Numbers: REB 09-072
First Posted: December 1, 2010    Key Record Dates
Last Update Posted: June 11, 2012
Last Verified: December 2009